X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Pfizer with AANJANEYA LIFECARE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PFIZER vs DR. DATSONS LABS - Comparison Results

PFIZER    Change

Pfizer India is a 71% subsidiary of the world's largest pharmaceuticals company Pfizer Inc. Pfizer derives a larger share of its revenues from the pharmaceuticals division (81%). The company also has presence in the animal health (13%) and clinical d... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PFIZER DR. DATSONS LABS PFIZER/
DR. DATSONS LABS
 
P/E (TTM) x 34.5 -10.9 - View Chart
P/BV x 4.9 0.2 3,001.8% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 PFIZER   DR. DATSONS LABS
EQUITY SHARE DATA
    PFIZER
Mar-18
DR. DATSONS LABS
Mar-14
PFIZER/
DR. DATSONS LABS
5-Yr Chart
Click to enlarge
High Rs2,365126 1,883.0%   
Low Rs1,62531 5,258.9%   
Sales per share (Unadj.) Rs430.3133.0 323.5%  
Earnings per share (Unadj.) Rs78.70.2 51,911.7%  
Cash flow per share (Unadj.) Rs93.26.6 1,410.2%  
Dividends per share (Unadj.) Rs20.000-  
Dividend yield (eoy) %1.00-  
Book value per share (Unadj.) Rs586.5128.8 455.4%  
Shares outstanding (eoy) m45.7531.66 144.5%   
Bonus/Rights/Conversions -FCCB-  
Price / Sales ratio x4.60.6 788.0%   
Avg P/E ratio x25.3516.1 4.9%  
P/CF ratio (eoy) x21.411.8 180.8%  
Price / Book Value ratio x3.40.6 559.9%  
Dividend payout %25.40-   
Avg Mkt Cap Rs m91,2712,477 3,684.2%   
No. of employees `0002.6NA-   
Total wages/salary Rs m3,14356 5,612.3%   
Avg. sales/employee Rs Th7,484.8NM-  
Avg. wages/employee Rs Th1,195.0NM-  
Avg. net profit/employee Rs Th1,369.1NM-  
INCOME DATA
Net Sales Rs m19,6854,211 467.5%  
Other income Rs m1,14379 1,452.2%   
Total revenues Rs m20,8284,289 485.6%   
Gross profit Rs m5,003569 879.9%  
Depreciation Rs m663204 324.1%   
Interest Rs m4430 1.0%   
Profit before tax Rs m5,47913 43,142.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m0-2 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,8786 30,793.4%   
Profit after tax Rs m3,6015 75,014.6%  
Gross profit margin %25.413.5 188.2%  
Effective tax rate %34.348.0 71.4%   
Net profit margin %18.30.1 16,045.1%  
BALANCE SHEET DATA
Current assets Rs m24,1676,852 352.7%   
Current liabilities Rs m9,5446,711 142.2%   
Net working cap to sales %74.33.3 2,218.2%  
Current ratio x2.51.0 248.0%  
Inventory Days Days55161 34.2%  
Debtors Days Days29318 9.0%  
Net fixed assets Rs m9,5143,673 259.0%   
Share capital Rs m458317 144.5%   
"Free" reserves Rs m26,3753,761 701.3%   
Net worth Rs m26,8324,078 658.1%   
Long term debt Rs m251,671 1.5%   
Total assets Rs m36,90012,633 292.1%  
Interest coverage x1,305.51.0 126,811.2%   
Debt to equity ratio x00.4 0.2%  
Sales to assets ratio x0.50.3 160.1%   
Return on assets %9.83.4 283.7%  
Return on equity %13.40.1 11,399.5%  
Return on capital %20.47.7 266.1%  
Exports to sales %022.9 0.0%   
Imports to sales %014.3 0.0%   
Exports (fob) Rs mNA964 0.0%   
Imports (cif) Rs mNA602 0.0%   
Fx inflow Rs m22964 2.3%   
Fx outflow Rs m1,489607 245.2%   
Net fx Rs m-1,466357 -410.8%   
CASH FLOW
From Operations Rs m3,3181,345 246.7%  
From Investments Rs m-2,383-2,256 105.6%  
From Financial Activity Rs m-1,104-1,200 92.0%  
Net Cashflow Rs m-169-2,111 8.0%  

Share Holding

Indian Promoters % 0.0 4.5 -  
Foreign collaborators % 63.9 0.0 -  
Indian inst/Mut Fund % 7.5 0.0 -  
FIIs % 4.9 1.4 363.0%  
ADR/GDR % 0.0 0.0 -  
Free float % 23.7 94.1 25.2%  
Shareholders   85,207 20,807 409.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PFIZER With:   VENUS REMEDIES  SHASUN PHARMA  SANOFI INDIA  TTK HEALTHCARE  ORCHID PHARMA LTD  

Compare PFIZER With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 629 Points Higher; Realty and Auto Stocks Witness Buying(Closing)

Indian share markets continued their momentum throughout the day and ended the day on a strong note. Gains were largely seen in the realty sector, telecom sector and auto sector.

Related Views on News

PFIZER Announces Quarterly Results (2QFY19); Net Profit Down 13.8% (Quarterly Result Update)

Nov 15, 2018 | Updated on Nov 15, 2018

For the quarter ended September 2018, PFIZER has posted a net profit of Rs 958 m (down 13.8% YoY). Sales on the other hand came in at Rs 5 bn (down 9.0% YoY). Read on for a complete analysis of PFIZER's quarterly results.

PFIZER Announces Quarterly Results (1QFY19); Net Profit Up 60.6% (Quarterly Result Update)

Aug 3, 2018 | Updated on Aug 3, 2018

For the quarter ended June 2018, PFIZER has posted a net profit of Rs 918 m (up 60.6% YoY). Sales on the other hand came in at Rs 5 bn (up 18.4% YoY). Read on for a complete analysis of PFIZER's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My Top 7 Stocks to Buy Now(The 5 Minute Wrapup)

Nov 30, 2018

Of all the stocks that you could buy in this market, I've picked the seven best safe stocks that offer the ideal combination of safety and profit.

4 Rebound Stocks to Profit from the Current Small Cap Crash(Profit Hunter)

Dec 3, 2018

Indian small cap space is offering a discount season. Make sure you do not get too late to scoop up the bargains.

Reliance CPSE ETF (FFO3): Should You Invest?(Outside View)

Nov 29, 2018

Personalfn's analysis note on Reliance Mutual Fund Central Public Sector Enterprises Exchange Traded Fund (CPSE ETF). Should you subscribe?

Safety Beats Growth in 2018(Chart Of The Day)

Nov 30, 2018

With the markets turning up, these are my top 7 stock picks.

Looking For Higher Interest Rates on Bank FDs? Read This!(Outside View)

Dec 5, 2018

Credit disbursement to the productive sectors of the economy such as infrastructure, engineering, food processing, textiles, and chemicals, among others is rising.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

PFIZER SHARE PRICE


Dec 12, 2018 (Close)

TRACK PFIZER

COMPARE PFIZER WITH

MARKET STATS